Lance JW. Mechanisms and management of headache. 5th edition, Oxford; Butterworth & Heinemann 1993
Moskowitz MA, Cutrer FM. Sumatriptan: a receptor-targeted treatment of migraine. Annu Rev Med 1993;44:145-154
Moskowitz MA. The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 1991;41:182-186
Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilation reversal by sumatriptan. Lancet 1991;338:13-17
Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-187
Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56
Moskowitz MA. Neurovascular mechanisms in the pathogenesis and treatment of migraine. Abstracts 7th World Congress on Pain. Seattle; IASP Publications 1993:253
Humphrey PPA. 5-Hydroxytryptamine and the pathophysiology of migraine. J Neurol 1991;238:S38-S44
Ferrari MD, Saxena PR. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 1993;13:151-165
Olesen J, Iversen HK, Thomsen LL. Nitric oxide supersensitivity. A possible molecular mechanism of migraine pain. Neuroreport 1993;4:1027-1030
Edmeads J. Migraine - disease or syndrome? Path Biol (Paris) 1992;40:279-283
Hardebo JE. A cortical excitatory wave may cause both the aura and the headache of migraine. Cephalalgia 1992;12:75-80
Leão AA. Spreading depression of activity in cerebral cortex. J Neurophysiol 1944;7: 359-390
Milner PM. Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão. EEG Clin Neurophysiol 1958;10:705
Lauritzen M, Skyhøj Olsen T, Lassen NA, Paulson OB. The changes of regional cerebral blood flow during the course of classical migraine attacks. Ann Neurol 1983a;13: 633-641
Lauritzen M, Skyhøj Olsen T, Lassen NA, Paulson OB. Regulation of regional cerebral blood flow during and between migraine attacks. Ann Neurol 1983b;14:569-572
Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation or rCBF in classic migraine. Ann Neurol 1981;9:344-352
Woods RP, Iacoboni M, Mazziotta JC. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331: 1689-1692
Barkley GL, Tepley N, Smikins R, Moran J, Welch KMA. Neuromagnetic fields in migraine: preliminary findings. Cephalalgia 1990;10:171-176
Schoenen J, Jamart B, Delwaide PJ. Cartographie électroencépaholographique dans les migraines en périodes critiques et intercritiques. Rev EEG Neurophysiol Clin 1987;17:289-299
Blau JN. Adult migraine: the patient observed. In: Blau JN ed Migraine, clinical, therapeutic, conceptual and research aspects. London; Chapman & Hall 1987:3-30
Schoenen J. Clinical neurophysiology studies in headache: a review of data and pathophysiological hints. Funct Neurol 1992;7:191-204
Maertens de Noordhout A, Timsit-Berthier M, Timsit M, Schoenen J. Contingent negative variation in headache. Ann Neurol 1986;19:78-90
Kropp P, Gerber WD. Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack. Cephalalgia 1995;15:123-128
Schoenen J, Maertens de Noordhout A, Timsit-Berthier M, Timsit M. Contingent negative variation (CNV) as a diagnostic and physiopathologic tool in headache patients. In: Clifford Rose F ed Migraine: clinical and research advances. Basel; Karger 1985:17-25
Kropp P, Gerber WD. Is increased amplitude of contingent negative variation in migraine due to cortical hyperactivity or to reduced habituation? Cephalalgia 1993;13: 37-41
Schoenen J, Wang W, Albert A, Delwaide PJ. Potentiation instead of habituation characterizes visual evoked potentials in migraine patients between attacks. European Journal of Neurology 1995;2:115-122
Afra J, Proietti Cecchini A, De Pasqua V, Albert A, Schoenen J. Visual evoked potentials during long-lasting pattern-reversal stimulations in migraine. Brain 1997 (in press)
Wang W, Schoenen, J, Timsit-Berthier M. Cognitive functions in migraine without aura between attacks: a psychophysiological approach using the "oddball" paradigm. Neurophysiologie Clinique, 1995;25:3-11
Wang W, Timsit-Berthier M, Schoenen J. Intensity dependence of auditory evoked potential in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology 1996;46:1404-1409
Mesulam MM. Large-scale neurocognitive networks and distributed processing for attention, language and memory. Ann Neurol 1990;28:597-613
Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993;33:173-187
Ferrari MD. Biochemistry of migraine. Path Biol (Paris) 1992;40:284-292
Grossberg S, Gutowski WE. Neural dynamics of decision making under rest: an effective balance and cognitive-emotional interactions. Psychol Rev 1987;94:300-318
Wang W, Timsit-Berthier M, Schoenen J. Negative correlation between sensation seeking behavior and intensity dependence of auditory evoked potentials in migraine. Cephalalgia 1995;15:65 (abstract)
Ophoff RA, Terwindt GM, Vergouwe MN et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+channel gene CACNL1A4. Cell 1996;87:543-552
Terwindt GM, Ophoff RA, Sandkuijl LA et al. For the Dutch Migraine Genetics Research Group. Involvement of the familial hemiplegic migraine gene on 19p13 in migraine with and without aura. Cephalalgia 1997;17:232 (abstract)
Weiller C, May A, Limmroth V et al. Brain stem activation in human migraine attacks. Nature Medicine 1995;1:658-660
Buchsbaum MS, Silverman J. Stimulus intensity control and the cortical evoked response. Psychosom Med 1968;30:12-22
Sappey-Marinier D, Calabrese G, Fein G, Hugg JW, Biggins C, Weiner MW. Effect of photic stimulation on human visual cortex lactate and phosphates using 1H and 31P magnetic resonance spectroscopy. J Cereb Blood Flow Metab 1992;12:584-592
Welch KMA, Levine SR, D'Andrea G, Schultz L, Helpern JA. Preliminary observations on brain energy metabolism in migraine studied by in vivo 31phosphorus NMR spectroscopy. Neurology 1989;39: 538-541
Barbiroli B, Montagna P, Cortelli P et al. Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 1992;42:1209-1214
Montagna P, Cortelli P, Monari L et al. 31P-Magnetic resonance spectroscopy in migraine without aura. Neurology 1994;44: 666-668
Montagna P, Sayuegna T, Cortelli P, Lugaresi E. Migraine as a defect of brain oxidative metabolism: a hypothesis. J Neurol 1989;236:124-125
Sangiorgi S, Mochi M, Riva R et al. Abnormal platelet mitochondrial function in patients affected by migraine with and without aura. Cephalalgia 1994;14:21-23
Watanabe H, Kuwabara T, Ohkubo M, Tsuji S, Yuasa T. Elevation of cerebral lactate detected by localized 1H-magnetic resonance spectroscpy in migraine during the interictal period. Neurology 1996;47:1093-1095
Ramadan NM, Halvorsen H, Vande-Linde A, Levine SR, Helpern JA, Welch KMA. Low brain magnesium in migraine. Headache 1989;29:590-593
Ferrari MD, Odink J, Bos KD, Malessy MJA, Bruyn GW. Neuroexcitatory plasma armino acids are elevated in migraine. Neurology 1990;40:1582-1586
D'Andrea G, Cananzi AR, Joseph R, et al. Platelet glycine, glutamate and aspartate in primary headache. Cephalalgia 1991;11: 197-200
Kennard C, Gawel M, Rudolf N, Clifford Rose F. Visual evoked potentials in migraine subjects. Research and Clinical Studies in Headache 1978;6:73-80
Diener HC, Scholz E, Dichgans J, Gerber WD. Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials. Ann Neurol 1989;25: 125-130
Besken E, Pothmann R, Sartory C. Contingent negative variation in childhood migraine. Cephalalgia 1993;13:42-43
Schoenen J, Maertens de Noordhout A, Timsit-Berthier M, Timsit M. Contingent negative variation and efficacy of beta-blocking agents. Cephalalgia 1986;6:229-233
Schoenen J, Maertens de Noordhout A. The role of the sympathetic nervous system in migraine and cluster headache. In: Olesen J, Edvinsson L eds Basic mechanisms of headache. Pain research and clinical management, vol. 2, Amsterdam: Elsevier 1988;393-410
Anthony M, Lance JW. Serotonin in migraine: In: Pearce JMS ed Topics in migraine. London; Heinemann 1975
D'Andrea G, Welch KMA, Riddle JM, Grunfeld S. Platelet serotonin metabolism and ultrastructure in migraine. Arch Neurol 1989;46:1187-1189
Ferrari MD, Odink J, Tapparelli C, Van Kempen GMJ, Pennings EJM, Bruyn GW. Serotonin metabolism in migraine. Neurology 1989;39:1239-1242
Olesen J, Friberg L, Olsen TS et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990;28:791-798
Olsen TS, Friberg L, Larsen NA. Ischemia may be the primary cause of the neurologic deficits in classic migraine. Arch Neurol 1987;44:156-161
Bès A, Fabre N, Soulages X, Pavy-Le-Traon A, Geraud G. La migraine est-elle une maladie vasculaire? Circulation et Métabolisme du Cerveau 1990;7:251-266
Thie A, Fuhlendorf A, Spitzer K, Kunze K. Transcranial doppler evaluation of common and classic migraine. Part II. Ultrasonic features during attacks. Headache 1990;30: 209-215
Caekebeke JFV, Ferrari MD, Zwetsloot CP, Jansen J, Saxena PR. Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks. Neurology 1992;42:1522-1526
Caekebeke JFV, Saxena PR, Ferrari MD. Effect of sumatriptan on cranial blood flow velocity during and between migraine attacks. In: Olesen J, Saxena PR eds Frontiers in headache research: 5-hydroxytryptamine mechanisms in primary headaches. New York; Raven Press 1992:273-277
Zwetsloot CP, Caekebeke JFV, Ferrari MD. Lack of asymmetry of middle cerebral artery blood velocity in unilateral migraine. Stroke 1993;24:1335-1338
Cutrer FM, Sorensen AG, Weisskoff RM, Ostergaard L, Rosen BR, Moskowitz MA. Brain perfusion defects during spontaneous migrainous aura identified by echo-planar magnetic resonance imaging. Cephalalgia 1997;17:254 (abstract)
Cao Y, Welch KMA, Aurora SK, Vikingstad E. Functional MRI (BOLD) of visually-triggered headache in migraine patients. Cephalalgia 1997;17:254 (abstract)
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.